NCT02805309

Brief Summary

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure for older adults with severe symptomatic aortic stenosis who are considered high risk for surgical aortic valve replacement. Despite symptomatic and survival benefits, many patients experience functional decline after TAVR. This pilot study aims to test the feasibility of a home-based exercise intervention targeting endurance, strength, and balance as well as cognitive behavioral intervention to improve physical functioning and disability after TAVR.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 20, 2016

Completed
1.1 years until next milestone

Study Start

First participant enrolled

August 1, 2017

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 6, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 6, 2020

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

July 21, 2021

Completed
Last Updated

July 21, 2021

Status Verified

June 1, 2021

Enrollment Period

2.8 years

First QC Date

June 11, 2016

Results QC Date

June 4, 2021

Last Update Submit

June 30, 2021

Conditions

Keywords

Transcatheter Aortic Valve ReplacementExerciseFrailtyFunctional OutcomesCognitive Behavioral Intervention

Outcome Measures

Primary Outcomes (1)

  • Change in the Late-Life Function and Disability Instrument (LLFDI) Score

    The LLFDI is a validated patient-reported outcome questionnaire that measures both functional limitations (inability to perform physical tasks - Activity Limitation Domain score, range: 0-100) and disability (inability to perform major life tasks and social roles - Participation Restriction Domain score, range: 0-100). For both scales, higher values indicate better function (lower limitation or lower disability). Two domain scores are analyzed separately.

    At baseline and week 8

Secondary Outcomes (4)

  • Change in the Short Physical Performance Battery (SPPB) Summary Score

    At baseline and week 8

  • Change in the 2-Minute Walk Distance (Feet)

    At baseline and week 8

  • Change in Dominant Hand Grip Strength (kg)

    At baseline and week 8

  • Number of Participants Who Experienced Adverse Events

    At week 8

Other Outcomes (5)

  • Change in Mini-Mental State Examination (MMSE) Score

    At baseline and week 8

  • Change in New York Heart Association (NYHA) Functional Class

    At baseline and week 8

  • Change in the Self-Efficacy Scale for Exercise (SEE)

    At baseline and week 8

  • +2 more other outcomes

Study Arms (3)

Exercise & Cognitive Behavioral Int.

EXPERIMENTAL

A physical therapist will make home visits, beginning within 1 week of discharge, to deliver an individualized exercise program and cognitive behavioral interventions.

Behavioral: ExerciseBehavioral: Cognitive behavioral interventions

Exercise Alone

EXPERIMENTAL

A physical therapist will make home visits, beginning within 1 week of discharge, to deliver an individualized exercise program, without cognitive behavioral interventions.

Behavioral: Exercise

Attention Control Education Program

ACTIVE COMPARATOR

Participants will receive telephone-based education sessions from a study health professional.

Behavioral: Attention control education program

Interventions

ExerciseBEHAVIORAL

Exercises will target balance, flexibility, strength, and endurance (source: https://go4life.nia.nih.gov/). Home visits will take place twice a week for week 1 and 2; once a week for week 3 and 4; every other week for week for week 5 through week 8. Participants are instructed to do prescribed exercises for 30 minutes daily. The duration of this intervention is about 40 mins.

Exercise & Cognitive Behavioral Int.Exercise Alone

The following cognitive-behavioral strategies will be employed: 1) enhance positive beliefs about exercise through discussion of benefits of exercise; 2) discussion of barriers to exercise; 3) individualized goal setting and self-monitoring progress using exercise calendar; 4) develop a detailed exercise plan on how, what, when, and where to conduct exercise; 5) $10 rewards for exercising ≥30 mins per day for ≥5 of 7 days. The duration of this intervention is about 20 mins.

Exercise & Cognitive Behavioral Int.

A health care professional will call the participant weekly for a period of 8 weeks to teach general tips about exercise and diet (source: https://go4life.nia.nih.gov/). No recommendations for a specific exercise program will be made, except for walking 30 minutes daily or as tolerated. Each telephone session will cover 4 exercise tips and 4 healthy eating tips. The duration of the intervention is about 30 minutes.

Attention Control Education Program

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥ 65 years
  • Underwent transcatheter aortic valve replacement
  • Lives within 20-mile radius of the recruiting site
  • Plan to be discharged home
  • Able to provide informed consent

You may not qualify if:

  • Stroke or any other medical disease that precludes participation in the exercise program
  • Severe cognitive impairment (Mini-Mental State Examination \< 15)
  • Current enrollment in another clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Brigham and Women's Hospital

Boston, Massachusetts, 02120, United States

Location

Hebrew SeniorLife

Boston, Massachusetts, 02131, United States

Location

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

Location

Related Publications (2)

  • Shi SM, Rapley FA, Margulis H, Laham RJ, Guibone K, Percy E, Kaneko T, Wang KY, Kim DH. Home-Based Rehabilitation After Transcatheter Aortic Valve Replacement (REHAB-TAVR): A Pilot Randomized Controlled Trial. J Am Geriatr Soc. 2025 Jun;73(6):1836-1846. doi: 10.1111/jgs.19456. Epub 2025 Apr 2.

  • Abraham LN, Sibilitz KL, Berg SK, Tang LH, Risom SS, Lindschou J, Taylor RS, Borregaard B, Zwisler AD. Exercise-based cardiac rehabilitation for adults after heart valve surgery. Cochrane Database Syst Rev. 2021 May 7;5(5):CD010876. doi: 10.1002/14651858.CD010876.pub3.

MeSH Terms

Conditions

Aortic Valve StenosisMotor ActivityFrailty

Interventions

Exercise

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow ObstructionBehaviorPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Limitations and Caveats

The primary outcome measure instrument, LLFDI Computer Adaptive Test software for Windows, could not be run after Windows operating system update during the study period. The software was not maintained by the developer to keep up with the latest version of the operating system. As a result, LLFDI measure was not measured for most participants at 8 weeks. The investigators measured a disability score (22 daily activities and physical tasks), which is highly correlated with LLFDI scores.

Results Point of Contact

Title
Dr. Dae Hyun Kim, Associate Scientist
Organization
Hebrew SeniorLife Marcus Institute for Aging Research

Study Officials

  • Dae Hyun Kim, MD, MPH, ScD

    Beth Israel Deaconess Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Physician

Study Record Dates

First Submitted

June 11, 2016

First Posted

June 20, 2016

Study Start

August 1, 2017

Primary Completion

May 6, 2020

Study Completion

May 6, 2020

Last Updated

July 21, 2021

Results First Posted

July 21, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations